REVB (STOCKS)
Revelation Biosciences, Inc. Common Stock
$1.202300
+0.032300 (+2.76%)
Prev close: $1.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James M. Rolke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.46M
- Employees
- 9
- P/E (TTM)
- -0.02
- P/B (TTM)
- 0.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-23.95 | $-3.73 | -20.2168 | -541.54% |
|
Sep 2025 (Q3)
|
$-7.08 | $-5.45 | -1.6332 | -29.98% |
|
Jun 2025 (Q2)
|
$-28.04 | $-18.18 | -9.8636 | -54.27% |
|
Mar 2025 (Q1)
|
$-25.32 | $-84.21 | +58.8912 | +69.93% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $157.17K |
| Operating Expenses | $9.07M |
| Research and Development | $4.06M |
| Other Operating Expenses | $5.01M |
| Operating Income/Loss | -$9.07M |
| Income/Loss From Continuing Operations After Tax | -$8.91M |
| Income/Loss From Continuing Operations Before Tax | -$8.91M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$8.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $5.95M |
| Preferred Stock Dividends And Other Adjustments | $5.95M |
| Basic Earnings Per Share | -$23.95 |
| Diluted Earnings Per Share | -$23.95 |
| Basic Average Shares | 620,785 |
| Diluted Average Shares | 620,785 |
| Assets | $11.58M |
| Current Assets | $10.81M |
| Noncurrent Assets | $771.30K |
| Fixed Assets | $18.07K |
| Other Non-current Assets | $753.23K |
| Liabilities | $2.72M |
| Current Liabilities | $2.00M |
| Accounts Payable | $577.50K |
| Other Current Liabilities | $1.42M |
| Noncurrent Liabilities | $723.77K |
| Equity | $8.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.86M |
| Liabilities And Equity | $11.58M |
| Net Cash Flow From Operating Activities | -$8.27M |
| Net Cash Flow From Operating Activities, Continuing | -$8.27M |
| Net Cash Flow From Investing Activities | -$4.20M |
| Net Cash Flow From Investing Activities, Continuing | -$4.20M |
| Net Cash Flow From Financing Activities | $12.47M |
| Net Cash Flow From Financing Activities, Continuing | $12.47M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.91M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.91M |
| Other Comprehensive Income/Loss | $0.00 |